Physician profile
Janine Marie Marti
NPI 1568918852
$500.27
in general payments reported to CMS, 2019-2025
8 companies · $476 in 2025
The $476 reported for 2025 was more than what 78% of Occupational Health (Nurse Practitioner) providers received nationally (typical 2025 total: $136).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $24.03 · 2025: $476.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $482 · Education: $18.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $482.27 |
| Education | $18.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $209.17 | 2025 | Inceptiv, Synchromedii |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $83.42 | 2025 | Relistor |
| Collegium Pharmaceutical, INC. | $58.01 | 2025 | Xtampza |
| Boston Scientific Corporation | $56.45 | 2025 | Intracept Rf Probe, Wavewriter Alpha Prime 16 |
| Averitas Pharma INC. | $33.62 | 2025 | Qutenza |
| Lantheus Medical Imaging, INC. | $24.03 | 2024 | |
| Valinor Pharma, LLC | $19.63 | 2025 | Movantik |
| Vertex Pharmaceuticals Incorporated | $15.94 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Janine Marti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.